Skip to content

ViralLoop

Your next post already worked.

←

Write from this board Add posts Share

AllXLinkedInInstagramTikTok

FilterOrderGridTableSelect

Loading the board

Moderna — how they publish · ViralLoop

Moderna — how they publish

Remix this board

10 posts · curated by ViralLoop

80 posts from @moderna_tx, Jul 2025 to Aug 2026: a typical post earns 31 likes. That is more than 81% of the 275 other S&P 500 companies we hold content for. About 1 in 2 of their posts announces something. Aug 2026 landed best: a median of 289 likes.

AllX LinkedIn Instagram TikTok

Moderna@moderna_tx

Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination

Opens with an observation

7.2K likes0 repliesIn reviewScienceX23d ago

Moderna@moderna_tx

Along with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage

Opens with an observation

639 likes0 repliesIn reviewScienceX23d ago

Moderna@moderna_tx

Today we announced that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER) has notified Moderna that it will not initiate a review of the biologics license application (BLA) for our investigational influenza vaccine, mRNA-1010, and

Opens with an announcement

533 likes0 repliesIn reviewScienceX7mo ago

Moderna@moderna_tx

Today we announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Applications for the 2026-2027 formulas for Spikevax® (COVID-19 Vaccine, mRNA) and mNEXSPIKE® (COVID-19 Vaccine, mRNA), containing the JN.1-lineage XFG subvariant of

Opens with an announcement

380 likes0 repliesIn reviewFood techX15d ago

Moderna@moderna_tx

Today we announced that the European Commission has granted marketing authorization for mNEXSPIKE® (mRNA-1283), a new COVID vaccine, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older. Read more: t.co

Opens with an announcement

314 likes0 repliesIn reviewMarketingX6mo ago

Moderna@moderna_tx

Today we announced that the U.S. Food and Drug Administration has approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older. This approval follows unanimous recommendations from the FDA's Vaccines and Related Biological

Opens with an announcement

197 likes0 repliesIn reviewFood techX1mo ago

Moderna@moderna_tx

Today we announced that the European Commission (EC) has granted marketing authorization for mCOMBRIAX® (mRNA-1083), our mRNA combination vaccine for active immunization for the prevention of influenza disease and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and

Opens with an announcement

188 likes0 repliesIn reviewMarketingX4mo ago

Moderna@moderna_tx

Today we announced that, in response to a prior Refusal-to-File letter, we engaged with the U.S. Food and Drug Administration (FDA) in a Type A meeting and proposed a revised regulatory approach for our investigational seasonal influenza vaccine candidate, mRNA-1010. Read more:

Opens with an announcement

188 likes0 repliesIn reviewHiringX6mo ago

Moderna@moderna_tx

Today we announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization in the European Union for mCOMBRIAX® (mRNA-1083), Moderna’s combination vaccine indicated for

Opens with an announcement

143 likes0 repliesIn reviewMarketingX6mo ago

Moderna@moderna_tx

Today we announced that the first mRNA vaccines fully manufactured in Canada are being shipped to Canadian provinces and territories. This milestone advances Canada’s domestic vaccine production capacity and strengthens national health security. Read more:

Opens with an announcement

120 likes0 repliesIn reviewProductX11mo ago

Boards are how ViralLoop learns your taste — save posts you admire, and turn the collection into content that sounds like you.

Start your own board